JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target.
LSPCF received commitments from institutional allocators, strategic corporate partners, family offices and HNWIs across North America, Europe, the Middle East and Asia, as well as JPMorgan Chase & Co. The fund close was led by CIO Stephen Squinto and Managing Partner Gaurav Gupta.
LSPCF invests in private biotechnology companies spanning cardiometabolic disease, oncology, immunology and genetic medicines.
Source:Private Equity Wire
Can’t stop reading? Read more
Exclusive Interview: Torge Barkholtz on rethinking SME succession through operator-led investing
Exclusive Interview: Torge Barkholtz on rethinking SME succession through operator-led investing...
Rightsizing the right way
Rightsizing the right way Rightsizing an organization is never easy. But, it is a normal process...
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion...
